Neobank Chime's high-profile IPO and Nucleus Genomics' controversial embryo-selection technology highlighted significant startup developments, while Automattic acquired Clay for portfolio…
Read More »Neobank Chime's high-profile IPO and Nucleus Genomics' controversial embryo-selection technology highlighted significant startup developments, while Automattic acquired Clay for portfolio…
Read More »